Beta Bionics closed an upsized IPO, raising approximately $212.1 million, trading on Nasdaq under the ticker BBNX. Beta Bionics, Inc. has successfully completed an upsized initial public offering, ...
"We delivered $32 million in net sales, which grew approximately 38% year-over-year" (President, CEO & Director Sean Saint), adding that growth was "driven predominantly by growth in new patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results